Brief: Heat Biologics To Showcase Favorable Survival Data Of Hs-110 In Previously Treated Non-Small Cell Lung Cancer Patients At 2021 American Society Of Clinical Oncology Annual Meeting
04/06/2021 15:36
June 4 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS TO SHOWCASE FAVORABLE SURVIVAL DATA OF
HS-110 IN
PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER PATIENTS AT 2021
AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING
Source text for Eikon: ID:nGNX22kTqn
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company